Numeric Investors’s West Pharmaceutical WST Stock Holding History

Numeric Investors’s Portfolio WST Stock Details WST Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q2	–	Sell	-14,100	Closed	-$1.15M	–	1175
2017 Q1	$1.15M	Buy	+14,100	New	+$1.18M	0.01%	608

Other funds holding WST

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return

Select Equity Group New York $19.5B AUM 17.33% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

BAMCO Inc New York $33.1B AUM 11.16% 1-Year Est. Return

EAM

Eagle Asset Management St Petersburg, Florida $19.6B AUM 41.58% 1-Year Est. Return

Numeric Investors's WST Position: Q2 2017 in Review

Numeric Investors sold out of West Pharmaceutical (WST) in Q2 2017, closing a stake of 14,100 shares — an estimated $1.15M sold.

Numeric Investors first reported a position in WST in Q1 2017 and held it in 1 quarter. The position peaked at $1.15M in Q1 2017. 309 funds tracked by Wall St. Rank hold WST as of Q2 2017.

Numeric Investors reported no remaining West Pharmaceutical position as of Q2 2017 after selling out during the quarter.
Numeric Investors sold 14,100 West Pharmaceutical shares in Q2 2017, an estimated $1.15M.
Numeric Investors first reported a position in West Pharmaceutical in Q1 2017 and held it in 1 quarter.
Numeric Investors's West Pharmaceutical position peaked at $1.15M in Q1 2017.
309 funds tracked by Wall St. Rank held West Pharmaceutical as of Q2 2017.

Based on Numeric Investors's 13F filing for Q2 2017, filed 14 Aug 2017.